Skip to content

Peripherally Inserted Central Catheter Insertion Site and Complication Rate in Neonates

Peripherally Inserted Central Venous Catheter Insertion Site and Complication Rates in Neonates

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03474978
Enrollment
320
Registered
2018-03-23
Start date
2018-10-19
Completion date
2025-12-31
Last updated
2023-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Catheterization, Peripheral

Brief summary

This study examines whether there is an association between the PICC insertion site and the complications necessitating PICC removal in neonates admitted to neonatal intensive care unit.

Interventions

DEVICEPeripherally Inserted Central Venous Cather (PICC)

Location of the PICC insertion will be randomized and compared

Sponsors

University of Calgary
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 4 Months
Healthy volunteers
No

Inclusion criteria

1. Neonates of all gestational ages admitted to Foothills Medical Centre and Alberta Children's Hospital Neonatal Intensive Care Unit (NICU) 2. Peripherally inserted central venous catheter (PICC) line insertion planned as part of NICU care 3. Venous access available in both upper(above umbilicus) and lower body

Exclusion criteria

1. Local infection at potential site of insertion 2. Hemangioma, lymphangioma or malformations in the region of insertion 3. Major chromosomal anomalies

Design outcomes

Primary

MeasureTime frameDescription
Primary outcome is the presence of any complication which necessitates PICC removalThrough study completion, within 4 weeksLine infiltration will be defined as extravasation of fluid into soft tissue around the region of the catheter tip. Line occlusion will be defined as inability to infuse fluid, resulting in removal of line. Phlebitis will be defined as presence of a linear red streak developing along the superficial veins from the catheter insertion site. Line associated thrombosis will be defined as ultrasound proven evidence of an occlusive thrombus in an anatomic location in proximity to the site of PICC.CLABSI will be defined according to Center for Disease Control definitions 26, that is, (1) confirmed primary bloodstream infection with (2) one of following clinical signs of infection (fever, hypothermia, apnea, or bradycardia) and (3) presence of central catheter at the time of or within 48 hours before the onset of the infection. Major life-threatening complications will include pleural effusion, pericardial effusion and cardiac tamponade, retroperitoneal extravasation.

Secondary

MeasureTime frameDescription
Secondary outcome will be time to complication post insertionThrough study completion, within 4 weeksThis will be defined as the interval between PICC line insertion and first detection of complication post insertion, expressed in days.

Countries

Canada

Contacts

Primary ContactAmuchou Soraisham, MD
amuchou.soraisham@ahs.ca403-944-8101

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026